investor_relations

Katy, Texas – September 11, 2026 -- Academy Sports + Outdoors (Nasdaq: ASO) will send Chief Executive Officer Steve Lawrence and Chief Financial Officer Carl Ford to the Goldman Sachs 33rd Annual Global Retailing Conference, running September 14 to September 15, 2026.

Executives will hold a fireside chat webcast on September 15

The session is scheduled for 11:30 a.m. Eastern Time on September 15 and will be webcast live for investors and analysts. A replay will remain available on the company's investor relations site for 30 days following the event.

Academy operates more than 300 stores across 21 states

The Katy, Texas-based sporting goods and outdoor recreation retailer traces its roots to 1938 as a Texas family business. Its product assortment spans outdoor gear, apparel, sports and recreation equipment, and footwear, combining national brands with a portfolio of private label lines.

Santa Clara, Calif. – September 11, 2026 -- Palo Alto Networks (NASDAQ: PANW) confirmed its management team will present at the Goldman Sachs Communacopia + Technology Conference on September 10, 2026, at 3:45 p.m. PT.

Executives to address investors at flagship Goldman Sachs tech event

The cybersecurity company disclosed the scheduled appearance as part of its ongoing investor relations calendar. A live audio webcast of the presentation will be made available through the "Investors" section of the company's corporate website.

Webcast access signals continued transparency push for institutional investors

Palo Alto Networks did not disclose additional details on presentation content or specific executives attending. The company noted that further information on upcoming investor events will be posted to its investor relations portal.

New York – September 11, 2026 -- Wolf Haldenstein Adler Freeman & Herz LLP has filed a securities class action against Hyliion Holdings Corp. (NYSE: HYLN) in the U.S. District Court for the Western District of Texas, covering investors who purchased shares between May 12, 2026 and June 23, 2026.

Complaint targets Hyliion's disclosures on the VFG Holdings power deal

The lawsuit alleges Hyliion overstated the substance of its May 12, 2026 non-binding Letter of Intent with VFG Holdings, which outlined up to 250 KARNO Cores and 50 MW of potential data-center power deployments over five years. Plaintiffs claim the company presented the VFG relationship and its broader commercial pipeline more favorably than the underlying facts supported. HYLN shares rose sharply following the May 12 announcement.

Sarasota, Fla. – September 11, 2026 -- Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York City from September 14-16, 2026.

CEO Kelvin Cooper to hold one-on-one investor meetings during three-day conference

Kelvin Cooper, Ph.D., chief executive officer of the clinical-stage biotechnology company, will deliver a virtual presentation and conduct one-on-one meetings with registered investors and potential partners. The sessions will cover Lakewood-Amedex's business and clinical development strategy, recent corporate achievements, and anticipated milestones.

Cheyenne, Wyoming – September 11, 2026 -- U.S. Gold Corp. (Nasdaq: USAU) will present its fully permitted CK Gold Project in Wyoming to investors at four separate conferences throughout September 2026, as the company seeks to build market awareness around a recently completed Feasibility Study.

Management targets four investor conferences across three U.S. cities

The company confirmed attendance at the Moody Capital Solutions Disruptive Growth & Life Sciences Conference in New York on September 9-10, followed by the H.C. Wainwright 28th Annual Global Investment Conference in New York from September 14-16. U.S. Gold will then travel to Colorado for the 2026 Precious Metals Summit in Beaver Creek, September 22-25, and Mining Forum Americas 2026 at The Broadmoor in Colorado Springs, September 27-30.

Los Angeles – September 11, 2026 -- Shareholders of Cogent Communications Holdings, Inc. (NASDAQ: CCOI) have until September 21, 2026, to seek lead plaintiff status in a securities fraud class action covering purchases made between February 29, 2024, and May 1, 2026.

Law firm Schall, Brown & Schwartz LLP alleges Cogent misrepresented its optical wavelength order backlog

According to the complaint filed by Schall, Brown & Schwartz LLP ('SBS'), Cogent's stated backlog of orders for optical wavelength products was unlikely to generate revenue because customers in that backlog were unwilling to accept delivery, even where the company was capable of fulfilling orders. The suit alleges the company was not on track to meet its revenue targets and other performance goals throughout the class period, rendering its public statements materially misleading under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5.

New York – September 10, 2026 -- Bluerock Private Real Estate Fund (NYSE: BPRE) has lifted its distribution rate to 7.0% of net asset value as of June 2026, up from 5.25% at its December 2025 listing, following four separate increases in six months.

Fund schedules October 6 webinar to detail capital rotation progress

BPRE will host a semi-annual progress report webinar on October 6, 2026, at 4:00 p.m. ET titled "BPRE Strategic Roadmap: A Progress Report." Chief Investment Officer Ryan MacDonald and Head of Listed Products Steven Baffico will present updates on the Fund's two-pillar strategy: shifting capital out of legacy core+ institutional real estate holdings into specialty direct property investments, and sustaining distribution growth.

Los Angeles – September 10, 2026 -- Schall, Brown & Schwartz LLP (SBS) has issued a reminder to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR) of a securities class action lawsuit alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The lead plaintiff deadline is set for September 28, 2026.

Lawsuit covers CAPR shares purchased between December 17, 2025 and July 26, 2026

The class action targets investors who purchased Capricor shares during this roughly seven-month window. Appointment as lead plaintiff is not a prerequisite for shareholders to participate in any eventual recovery.

Los Angeles – September 10, 2026 -- Schall, Brown & Schwartz LLP has filed a class action lawsuit against Blaize Holdings, Inc. (NASDAQ: BZAI), alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The lawsuit covers investors who purchased BZAI shares between July 18, 2025 and April 28, 2026, with a lead plaintiff filing deadline set for October 5, 2026.

Complaint alleges Blaize recognized revenue from entities lacking meaningful business activity

According to the complaint, Blaize created an appearance of growth by announcing transactions with counterparties that were not capable of meaningful business operations. The company then improperly recognized revenue from these arrangements, rendering its public statements throughout the class period false and materially misleading, the filing states.

Los Angeles – September 10, 2026 -- DJS Law Group has reminded shareholders of a class action lawsuit filed against Beta Bionics, Inc. (NASDAQ: BBNX) alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The suit covers investors who purchased BBNX shares between July 30, 2025 and February 24, 2026, with a lead plaintiff filing deadline set for November 3, 2026.

Complaint alleges Beta Bionics downplayed FDA findings on its iLet insulin pump

The complaint centers on the iLet Bionic Pancreas insulin pump, Beta Bionics' sole commercialized product. After the company disclosed that the FDA had issued a Form 483 following a manufacturing facility inspection, defendants allegedly told investors the agency's observations were limited to complaint-reporting criteria and did not reflect underlying device problems.